https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-12-09 / Eur. J. Immunol. 2011 Jan;41(1):18-25
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-12-09 / Eur. J. Immunol. 2011 Jan;41(1):18-252010-12-09 00:00:002019-02-15 08:40:11Guiding the „misguided“ – functional conditioning of dendritic cells for the DC-based immunotherapy against tumours
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-12-06 / Clin. Cancer Res. 2011 Mar;17(6):1603-15
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-12-06 / Clin. Cancer Res. 2011 Mar;17(6):1603-152010-12-06 00:00:002019-02-15 08:46:43Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-12-01 / Anticancer Res. 2010 Dec;30(12):5091-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-12-01 / Anticancer Res. 2010 Dec;30(12):5091-72010-12-01 00:00:002019-02-15 08:46:02Immunogenicity of dendritic cells pulsed with CEA peptide or transfected with CEA mRNA for vaccination of colorectal cancer patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-12-01 / Int. J. Oncol. 2010 Dec;37(6):1439-52
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-12-01 / Int. J. Oncol. 2010 Dec;37(6):1439-522010-12-01 00:00:002021-11-15 16:59:47Transcriptome analysis and cytokine profiling of naive T cells stimulated by a tumor vaccine via CD3 and CD25
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-12-01 / Curr Opin Investig Drugs 2010 Dec;11(12):1399-408
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-12-01 / Curr Opin Investig Drugs 2010 Dec;11(12):1399-4082010-12-01 00:00:002019-02-15 08:49:21New approaches to the development of adenoviral dendritic cell vaccines in melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-11-30 / Mol Med Rep 2011 Jan-Feb;4(1):187-91
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-11-30 / Mol Med Rep 2011 Jan-Feb;4(1):187-912010-11-30 00:00:002019-02-15 08:35:41Effect of hyperthermia on the apoptosis and proliferation of CaSki cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-11-15 / Oncology (Williston Park, N.Y.) 2010 Nov;24(12):1161, 1166
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-11-15 / Oncology (Williston Park, N.Y.) 2010 Nov;24(12):1161, 11662010-11-15 00:00:002019-02-15 09:17:24Hyperthermia and intravesical therapy: emerging one-two punch for bladder cancer?
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-11-15 / Oncology (Williston Park, N.Y.) 2010 Nov;24(12):1149-55
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-11-15 / Oncology (Williston Park, N.Y.) 2010 Nov;24(12):1149-552010-11-15 00:00:002019-02-15 09:17:25Hyperthermia as a treatment for bladder cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-11-11 / Cancer Immunol. Immunother. 2011 Feb;60(2):249-60
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-11-11 / Cancer Immunol. Immunother. 2011 Feb;60(2):249-602010-11-11 00:00:002019-02-15 08:49:22Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-11-11 / Radiother Oncol 2010 Dec;97(3):535-40
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-11-11 / Radiother Oncol 2010 Dec;97(3):535-402010-11-11 00:00:002010-11-11 00:00:00Durable palliation of breast cancer chest wall recurrence with radiation therapy, hyperthermia, and chemotherapy
